<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The aim of this work was to verify neuroprotective and anti-inflammatory properties of FBD, a herbal formula composed of Poria cocos, Atractylodes macrocephala and Angelica sinensis, in ICR mice subjected to repetitive 10 min of common carotid <z:mp ids='MP_0006134'>arteries occlusion</z:mp> followed 24 h reperfusion </plain></SENT>
<SENT sid="1" pm="."><plain>Intragastrical pretreatment with supercritical carbon dioxide extract (FBD-<z:chebi fb="0" ids="16526">CO(2)</z:chebi>, 37.5 mg/kg) twice daily for 3.5 d, significantly reduced Evans Blue influx, neuron specific enolase (NSE) efflux, <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> (<z:hpo ids='HP_0000001'>all</z:hpo> p&lt;0.05), also inhibited polymorphonuclear leukocytes (PMNs) infiltration (p&lt;0.001), suppressed secretion of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor (TNF)-alpha in blood (p&lt;0.05), interleukin (IL)-1beta and IL-8 in brain (both p&lt;0.01), and down-regulated cerebral expression of <z:chebi fb="27" ids="28659">phosphor</z:chebi>-IkappaB-alpha and <z:chebi fb="27" ids="28659">phosphor</z:chebi>-nuclear factor kappa-B (NF-kappaB), whether coupled with aqueous extract (FBD-<z:chebi fb="0" ids="15377">H(2)O</z:chebi>, 150 mg/kg) or not </plain></SENT>
<SENT sid="2" pm="."><plain>Moreover, FBD-<z:chebi fb="0" ids="16526">CO(2)</z:chebi> (0.1-10 microg/ml) inhibited 0.1 microM <z:chebi fb="0" ids="8116">phorbol</z:chebi> <z:chebi fb="0" ids="30807">myristate</z:chebi> <z:chebi fb="49" ids="30089,47622">acetate</z:chebi>-evoked oxidative burst in rat PMNs, 20 ng/ml TNF-alpha-triggered PMNs <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> to ECV304 endothelial cells, and PMNs neurotoxicity to PC12 neuron-like cells as well as NSE release (IC(50) 1.30, 0.98, 0.24 and 0.82 microg/ml, respectively) </plain></SENT>
<SENT sid="3" pm="."><plain>Our study demonstrated that FBD-<z:chebi fb="0" ids="16526">CO(2)</z:chebi> prevented <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e>/reperfusion injury, at least in part, by limiting PMNs infiltration and neurotoxicity mediated by TNF-alpha, IL-1beta and IL-8, via inhibition on NF-kappaB activation </plain></SENT>
</text></document>